HIGHLIGHTS
- who: Jing Li from the A phase III trial is being conducted in Shanghai Jiaotong University Medical School affiliated with Ruijin Hospital have published the research: Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer, in the Journal: (JOURNAL) of 24/08/2019
- what: This study showed a good response rate achieved by cisplatin and paclitaxel followed by standard The aim of this interim analysis is to confirm the efficacy and adverse events (AEs) of NACT in cervical cancer patients. The approach is now being evaluated in a randomized . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.